This suggests that the programmed cell death protein-1 (PD-1)/PD-L1 immune checkpoint mechanism [23] is involved at the tumour site, and therefore, treatment with PD-1/PD-L1 inhibitors alone should be effective. This evidence concerns the gene CD274 and neoplasm.